Log In
Print this Print this

Subcutaneous XmAb7195

  Manage Alerts
Collapse Summary General Information
Company Xencor Inc.
DescriptionHumanized mAb targeting IgE and Fc gamma receptor IIb (FCGR2B; CD32B)
Molecular Target Immunoglobulin E (IgE) ; Fc gamma receptor IIb (FCGR2B) (CD32B)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard Indication Inflammation (unspecified)
Indication DetailsTreat atopic diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today